TimesSquare Capital Management LLC Sells 158,298 Shares of HealthEquity, Inc. (NASDAQ:HQY)

TimesSquare Capital Management LLC lessened its stake in HealthEquity, Inc. (NASDAQ:HQY) by 70.9% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 65,000 shares of the company’s stock after selling 158,298 shares during the quarter. TimesSquare Capital Management LLC owned approximately 0.08% of HealthEquity worth $6,237,000 at the end of the most recent quarter.

A number of other hedge funds also recently modified their holdings of HQY. Creative Planning grew its stake in HealthEquity by 18.6% in the 3rd quarter. Creative Planning now owns 23,632 shares of the company’s stock valued at $1,934,000 after buying an additional 3,706 shares in the last quarter. Raymond James & Associates grew its stake in HealthEquity by 1.3% in the 3rd quarter. Raymond James & Associates now owns 151,318 shares of the company’s stock valued at $12,385,000 after buying an additional 1,911 shares in the last quarter. Sequoia Financial Advisors LLC grew its stake in HealthEquity by 2.3% in the 3rd quarter. Sequoia Financial Advisors LLC now owns 13,314 shares of the company’s stock valued at $1,090,000 after buying an additional 303 shares in the last quarter. Private Advisor Group LLC purchased a new position in HealthEquity in the 3rd quarter valued at approximately $208,000. Finally, Wealth Enhancement Advisory Services LLC grew its stake in HealthEquity by 18.8% in the 3rd quarter. Wealth Enhancement Advisory Services LLC now owns 3,649 shares of the company’s stock valued at $299,000 after buying an additional 578 shares in the last quarter. Institutional investors own 99.55% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently commented on HQY. BTIG Research boosted their price target on shares of HealthEquity from $110.00 to $130.00 and gave the company a “buy” rating in a research report on Thursday, November 14th. Royal Bank of Canada boosted their price target on shares of HealthEquity from $100.00 to $105.00 and gave the company an “outperform” rating in a research report on Tuesday, December 10th. JMP Securities boosted their price target on shares of HealthEquity from $105.00 to $107.00 and gave the company a “market outperform” rating in a research report on Tuesday, December 10th. Bank of America boosted their price target on shares of HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. Finally, Mizuho began coverage on shares of HealthEquity in a research report on Wednesday, December 4th. They set an “outperform” rating and a $126.00 price target for the company. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $110.71.

HealthEquity Stock Performance

HealthEquity stock opened at $113.74 on Thursday. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $9.86 billion, a PE ratio of 104.35, a P/E/G ratio of 1.62 and a beta of 0.55. The firm has a fifty day simple moving average of $103.06 and a two-hundred day simple moving average of $91.63. HealthEquity, Inc. has a twelve month low of $65.01 and a twelve month high of $115.59.

HealthEquity (NASDAQ:HQY) last posted its quarterly earnings results on Monday, December 9th. The company reported $0.59 earnings per share for the quarter, missing the consensus estimate of $0.71 by ($0.12). HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. During the same quarter in the prior year, the company earned $0.40 earnings per share. Research analysts expect that HealthEquity, Inc. will post 2.32 EPS for the current year.

Insiders Place Their Bets

In other news, Director Robert W. Selander sold 5,750 shares of the company’s stock in a transaction dated Monday, February 10th. The shares were sold at an average price of $111.29, for a total transaction of $639,917.50. Following the completion of the transaction, the director now directly owns 78,219 shares of the company’s stock, valued at approximately $8,704,992.51. This represents a 6.85 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Director Stuart B. Parker sold 25,000 shares of the company’s stock in a transaction dated Thursday, December 12th. The shares were sold at an average price of $96.72, for a total transaction of $2,418,000.00. Following the transaction, the director now directly owns 19,061 shares of the company’s stock, valued at approximately $1,843,579.92. This trade represents a 56.74 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 39,000 shares of company stock valued at $3,895,788 over the last three months. Insiders own 2.20% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.